Targeting RNA modifications in leukaemia: Epitranscriptomic drugs are the new kids on the block

Manel Esteller
DOI: https://doi.org/10.1111/bjh.19894
2024-11-13
British Journal of Haematology
Abstract:In this article, Chen et al. show that a chemical modification of transfer RNA, along its corresponding RNA modifier enzyme, is diminished in acute myeloid leukaemia. These findings further support the role of an aberrant epitranscriptome in haematological malignancies. Commentary on: Chen et al. Hydroxy‐wybutosine tRNA modifications as indicators of disease progression and therapeutic targets in leukemia. Br J Haematol 2024 (Online ahead of print). doi: 10.1111/bjh.19873.
hematology
What problem does this paper attempt to address?